Organoid-Guided Precision Medicine: From Bench to Bedside

Area of Science:

• Biotechnology and Biomedical Engineering
• Regenerative Medicine
• Genomics and Personalized Medicine

Background:

• Organoid technology represents a significant advancement in biotechnology.
• Organoids recapitulate physiological architectures and disease phenotypes in 3D culture systems.
• They utilize scaffolds, stem cells, and cytokine regulation to mimic tissue microenvironments.

Purpose of the Study:

• To systematically review the translational trajectory of organoids from research to clinical application.
• To emphasize organoid construction, regulatory factors, and applications in personalized healthcare.
• To highlight organoids' role in drug development, diagnostics, and regenerative strategies.

Main Methods:

• Three-dimensional (3D) culture systems utilizing natural and synthetic scaffolds.
• Employment of diverse stem cell sources for organoid generation.
• Spatiotemporal cytokine regulation to model tissue-specific microenvironments.
• Integration of multiomics analyses and clustered regularly interspaced short palindromic repeats (CRISPR)-based screens.

Main Results:

• Diverse organoid types (skin, intestinal, lung, tumor) have enabled breakthroughs in modeling development, drug screening, and disease pathogenesis.
• Patient-derived tumor organoids accurately reflect tumor heterogeneity and genomic profiles for predicting chemotherapy response.
• Organoid-guided analyses identify biomarkers and resistance mechanisms, optimizing therapeutic targeting.

Conclusions:

• Organoids are revolutionizing precision medicine by bridging molecular insights with patient-specific therapies.
• They provide dynamic platforms for drug development, regenerative strategies, and individualized treatment paradigms.
• Future integration with AI, microfluidics, and spatial transcriptomics will enhance clinical relevance and scalability.